Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease

Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease

Abstract Buerger's disease or thromboangiitis obliterans is a type of obstructive vascular diseases categorized as vasculitis and usually present in 95% of young smoker men. The main pathogenetic mechanism is interplay between immune system and inflammation. Earlier our phase II study has shown...

Full description

Bibliographic Details
Main Authors: Pawan Kumar Gupta, Santanu Dutta, Sanjay Kala, Muralikrishna Nekkanti, Sanjay C. Desai, Subhendu S. Mahapatra, Anita Dhar, Radhakrishnan Raju, Rajkumar M., Arunanshu Behera, Shivashankar P., N.S. Raviraja, Pachaiyappan Viswanathan, Mithun Chandrashekar, Charan Thej, Prasanth K.V., Jijy Abraham, Hema Boggarapu, K. Udaykumar
Format: Article
Language:English
Published: Oxford University Press 2021-12-01
Series:Stem Cells Translational Medicine
Subjects:
angiogenesis
ankle brachial pressure index
critical limb ischemia
mesenchymal stromal cells
rest pain score
Rutherford III‐5 or III‐6
Online Access:https://doi.org/10.1002/sctm.21-0197

Internet

https://doi.org/10.1002/sctm.21-0197

Similar Items